This article is the first in a new series that details available clinical trials and offers information on how you and your practice can participate. The CALGB/SWOG 80405 trial is designed to assess the optimal combination of biological agents and chemotherapy for the first-line treatment of patients with advanced or metastatic colorectal cancer.
|Original language||English (US)|
|Number of pages||6|
|State||Published - Sep 2006|
ASJC Scopus subject areas